Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue: +22.7%
EPS: −38.4%
Free cash flow: −38.2%
Total debt: +100.9%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

42.93 1.39 −3.14%

Follow PBH

Alert me

Market cap: $2.1B
P/E: 13.7×
Fwd P/E: 11.7×
Dividend yield: —
F-score: 5/9
Altman Z: 2.48
Beneish M: −2.53
Dividend safety: n/a

Overview

Prestige Consumer Healthcare Inc. (PBH) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a P/E ratio of 13.7×. Over the past ten years it has ranged from 0.0× (March 2024) to 44.0× (July 2016); the current reading is higher than 38% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 20.5× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PBH/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Prestige Consumer Healthcare Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PBH/metrics/pe-ratio">Prestige Consumer Healthcare Inc. (PBH) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2026	15.0×	(24.41%)
FY2025	19.9×	16.88%
FY2024	17.0×	—
FY2023	0.0×	—
FY2022	13.0×	(3.45%)
FY2021	13.4×	3.32%
FY2020	13.0×	—
FY2019	0.0×	—
FY2018	5.2×	(87.75%)
FY2017	42.1×	49.00%

Period	P/E ratio	Change
Sep 2026	14.1×	6.86%
Jun 2026	13.2×	(12.47%)
Mar 2026	15.0×	(7.09%)
Dec 2025	16.2×	5.35%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 44.0×

Ten-year median 15.0×

Current reading's percentile 28

Company	P/E ratio
XERS Xeris Biopharma Holdings, Inc. compare	n/m
PRGO Perrigo Company plc compare	n/m
BCRX BioCryst Pharmaceuticals, Inc. compare	n/m
ALVO Alvotech compare	n/m
RGC Regencell Bioscience Holdings Limited compare	n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
AMLX Amylyx Pharmaceuticals, Inc. compare	n/m
TRLV Trulieve Cannabis Corp. compare	n/m
PBH Prestige Consumer Healthcare Inc.	13.7×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Prestige Consumer Healthcare Inc. (PBH) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PBH

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PBH

Stockrow Weekly